Sign up for our newsletter and get the latest HPC news and analysis.
Send me information from insideHPC:


Hartree Centre Collaborates to Transform UK Pharmaceutical Development

A new major collaborative project is set to transform the UK pharmaceutical industry by enabling the manufacturing processes of the innovative medicines of the future to be designed digitally. The STFC Hartree Centre is a partner in the £20.4m ADDoPT (Advanced Digital Design of Pharmaceutical Therapeutics) project, which involves major pharmaceutical companies, Pfizer, GSK, AstraZeneca and Bristol-Myers Squibb.